The Record: File 452 (cont'd)

References: 
Wood, J. et al., "Pharmacological profile of a potent and orally active
inhibitor of VEGF receptor tyrosine kinases", Proc Am Assoc Cancer Res
(AACR) 1998,39 Abst 655

Drevs, J. et al., "Phase I dose escalation, pharmacokinetic (pk) study
of a novel vascular endothelial growth factor (VEGF) receptor inhibitor,
PTK787/ZK 222584 (PTK/ZK)", Eur J Cancer 1999,35(Suppl. 4) Abst 1137

Manley, P.W. et al., "Rationalization of the selective inhibition of
VEGF-tyrosine kinase by the angiogenesis inhibitor, PTK787/ZK222584 (1) 
on the basis of shape complementarity to hydrophobic domains within the
ATP-binding site", AACR-NCI-EORTC Int Conf Mol Targets Cancer Ther (Nov
16-19, Washington DC) 1999, Abst 256

Xu, L. et al., "Therapy of VEGF-dependent human ovarian carcinoma by
oral administration of CGP 79787/ZK222584, an inhibitor of the VEGF
receptor tyrosine kinase", Proc Am Assoc Cancer Res (AACR) 1999,40 Abst
3020

Ozaki, H. et al., "Blockade of vascular endothelial cell growth factor
receptor signaling is sufficient to completely prevent retinal
neovascularization", Am J Pathol 2000,156(2): 697

Wood, J.M. et al., "Vascular endothelial growth factor receptor
tyrosine kinase inhibition, an effective therapy against human prostatic
carcinomas in nude mice", Proc Am Assoc Cancer Res (AACR) 2000,41 Abst 
299

Wood, J.M. et al., "Magnetic resonance imaging of tumor permeability: A
non-invasive marker for the efficacy of a VEGF-receptor tyrosine kinase
inhibitor", Proc Am Assoc Cancer Res (AACR) 2000,41 Abst 2460

Soorzano, C.C. et al., "Blockade of VEGF-R signaling inhibits growth
and metastasis of human pancreatic cancer", Proc Am Assoc Cancer Res 
(AACR) 2000,41 Abst 3620

Wood, J.M. et al., "PTK787/ZK 222584, a novel and potent inhibitor of
vascular endothelial growth factor receptor tyrosine kinases, impairs
vascular  endothelial growth factor-induced responses and tumor growth
after oral administration", Cancer Res 2000,60(8): 2178

Bold, G. Altmann, K.-H. Frei, J. et al., "New anilinophthalazines as
potent and orally well absorbed inhibitors  of the VEGF receptor tyrosine
kinases useful as antagonists of tumor-driven angiogenesis", J Med Chem
2000,43(12): 2310

Manley, P.W. Bold, G. Furet, P. Hofmann, F. Wood, J.M., "SAR studies on
the angiogenesis inhibitor, PTK787/ZK222584 (1)", 27th Natl Med Chem Symp
(June 13-17, Kansas City) 2000, Abst A-20

Bold, G. Altmann, K.-H. Frei, J. et al., "New anilinophthalazines as
potent and orally well absorbed inhibitors  of the VEGF receptor tyrosine
kinases useful as antagonists of tumor-driven angiogenesis. (Erratum)", J
Med Chem 2000,43(16): 3200